{"transactions":[{"id":1110947,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:10:10.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director."}],"balance_after":27000,"derivative":{"exercise_price":1.29,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000950170-25-086172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017025086172/ownership.xml","form_type":"4"}},{"id":1494754,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to  buy)","published_at":"2024-06-03T21:13:53.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001650664-24-000070","document":"wk-form4_1717449223.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000070/wk-form4_1717449223.xml","form_type":"4"}},{"id":1501439,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-24T23:46:59.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 24, 2024. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director."}],"balance_after":17500,"derivative":{"exercise_price":4.88,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-24-064836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000095017024064836/ownership.xml","form_type":"4"}},{"id":1844815,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:49:42.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 21, 2023. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director."}],"balance_after":13200,"derivative":{"exercise_price":2.81,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0000899243-23-016376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924323016376/doc4.xml","form_type":"4"}},{"id":1866067,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-05T20:30:09.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 1, 2023 and is scheduled to vest in full on June 1, 2024."}],"balance_after":25000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-23-009230","document":"form4-06052023_040602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923009230/form4-06052023_040602.xml","form_type":"4"}},{"id":2233631,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:30:18.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 9, 2022 and is scheduled to vest in full on June 9, 2023."}],"balance_after":25000,"derivative":{"exercise_price":12.31,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-22-006488","document":"form4-06132022_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588922006488/form4-06132022_040601.xml","form_type":"4"}},{"id":2243539,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:39:16.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":7733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 1, 2022. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director."}],"balance_after":7733,"derivative":{"exercise_price":3.43,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":7733},"source":{"system":"sec-edgar","filing":"0000899243-22-020980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000089924322020980/doc4.xml","form_type":"4"}},{"id":2530258,"issuer":{"id":7244,"kind":"organization","name":"Werewolf Therapeutics, Inc."},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T20:12:15.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":23200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 28, 2021. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter."}],"balance_after":23200,"derivative":{"exercise_price":15.97,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":23200},"source":{"system":"sec-edgar","filing":"0001785530-21-000047","document":"wf-form4_163579752074123.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1785530/000178553021000047/wf-form4_163579752074123.xml","form_type":"4"}},{"id":2678741,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T20:13:05.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":11538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 3, 2021 and is scheduled to vest in full on June 3, 2022."}],"balance_after":11538,"derivative":{"exercise_price":33.36,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":11538},"source":{"system":"sec-edgar","filing":"0001179110-21-006452","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911021006452/edgar.xml","form_type":"4"}},{"id":2937258,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":78493,"kind":"person","name":"Chatterjee Meeta","position":1,"cik":"0001835388","reported_name":"Chatterjee Meeta","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T21:41:22.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":23076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 17, 2020 and is scheduled to vest over three years in equal yearly installments of one-third of the shares beginning on December 17, 2021 through December 17, 2023."}],"balance_after":23076,"derivative":{"exercise_price":62.71,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":23076},"source":{"system":"sec-edgar","filing":"0001179110-20-012101","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020012101/edgar.xml","form_type":"4"}}]}